Safety and Tolerability Study of an Intravenously Administered Small Interfering Ribonucleic Acid (siRNA) Post On-Pump Cardiothoracic Surgery in Patients at Risk of Acute Kidney Injury-Reference-Cited by-同舟云学术

Safety and Tolerability Study of an Intravenously Administered Small Interfering Ribonucleic Acid (siRNA) Post On-Pump Cardiothoracic Surgery in Patients at Risk of Acute Kidney Injury

Published:2017-09 Issue:5 Volume:2 Page:836-843
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Demirjian Segav,Ailawadi Gorav,Polinsky Martin,Bitran Dani,Silberman Shuli,Shernan Stanton Keith,Burnier Michel,Hamilton Marta,Squiers Elizabeth,Erlich Shai,Rothenstein Daniel,Khan Samina,Chawla Lakhmir S.

Publisher

Elsevier BV

Subject

Nephrology

Reference20 articles.

1. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients;Chertow;J Am Soc Nephrol,2005

2. Association between AKI and long-term renal and cardiovascular outcomes in United States veterans;Chawla;Clin J Am Soc Nephrol,2014

3. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery;Hobson;Circulation,2009

4. KDIGO clinical practice guideline for acute kidney injury;Kidney Int Suppl,2012

5. siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury;Molitoris;J Am Soc Nephrol,2009

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment with siRNAs is commonly associated with GPX4 up-regulation and target knockdown-independent sensitization to ferroptosis;Science Advances;2024-03-15

2. PROGRESS OF OLIGONUCLEOTIDE THERAPEUTICS TARGET TO RNA;Nucleic Acids in Medicinal Chemistry and Chemical Biology;2022-12-16

3. Incidence, risk factors and prognosis of acute kidney injury in patients treated with immune checkpoint inhibitors: a retrospective study;Scientific Reports;2022-11-05

4. Plasmacytoma Variant Translocation 1 (PVT1) Gene as a Potential Novel Target for the Treatment of Diabetic Nephropathy;Biomedicines;2022-10-26

5. Therapeutic siRNA: State-of-the-Art and Future Perspectives;BioDrugs;2022-08-23